Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a ‘transdifferentiation’ during the clonal evolution

References

• Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992;80:758–767.
   PubMed Web of Science ®Google Scholar
• Mao Z, Quintanilla-Martinez L, Raffeld M, et al IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 2007;31:1605–1614.
   PubMed Web of Science ®Google Scholar
• Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004;117:663–676.
   PubMed Web of Science ®Google Scholar
• Laiosa CV, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006;25:731–744.
   PubMed Web of Science ®Google Scholar
• Cossu A, Deiana A, Lissia A, et al Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node. Arch Pathol Lab Med 2006;130:544–547.
   PubMed Web of Science ®Google Scholar
• Wetzeler M, Kurzrock R, Goodacre AM, McLaughlin P, Ku S, Talpaz M. Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type. Cancer 1995;76:609–617.
   PubMed Web of Science ®Google Scholar
• Alvaro T, Bosch R, Salvadó MT, Piris MA. True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma. Am J Surg Pathol 1996;20:1406–1411.
   PubMed Web of Science ®Google Scholar
• Bassarova A, Trøen G, Fosså A, et al Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation. J Hematop 2009;2:135–141.
   PubMedGoogle Scholar
• Zhang D, McGuirk J, Ganguly S, Persons DL. Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature. Int J Hematol 2009;89:529–532.
   PubMed Web of Science ®Google Scholar
• Feldman AL, Arber DA, Pittaluga S, et al Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111:5433–5439.
   PubMed Web of Science ®Google Scholar
• Jaffe R, Pileri SA, Facchetti F, Jones DM, Jaffe ES. Histiocytic and dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 354–367.
   Google Scholar
• Favara BE, Feller AC, Pauli M, et al Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157–166.
   PubMedGoogle Scholar
• Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002;94:1204–1210.
   PubMed Web of Science ®Google Scholar
• Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007;449:473–477.
   PubMed Web of Science ®Google Scholar
• Xie H, Orkin SH. Immunology: changed destiny. Nature 2007;449:410–411.
   PubMed Web of Science ®Google Scholar
• Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol 2004;5:248–250.
   PubMed Web of Science ®Google Scholar
• Jabari S, Meissnitzer M, Quint K, et al Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo. Int J Oncol 2009;35:69–80.
   PubMed Web of Science ®Google Scholar
• Magni M, Di Nicola M, Carlo-Stella C, et al Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk Res 2002;26:1131–1133.
   PubMed Web of Science ®Google Scholar
• Hou YH, Srour EF, Ramsey H, Dahl R, Broxmeyer HE, Hromas R. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood 2005;105:3488–3492.
   PubMed Web of Science ®Google Scholar
• Latchman DS. The Oct-2 transcription factor. Int J Biochem Cell Biol 1996;28:1081–1083.
   PubMed Web of Science ®Google Scholar
• Emslie D, D'Costa K, Hasbold J, et al Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells. J Exp Med 2008;205:409–421.
   PubMed Web of Science ®Google Scholar
• Chen W, Lau SK, Fong D, et al High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas. Am J Surg Pathol 2009;33:863–873.
   PubMed Web of Science ®Google Scholar
• Kusam S, Dent A. Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6. Immunol Res 2007;37:177–186.
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Chang CC, Cechova K, et al BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45–53.
   PubMed Web of Science ®Google Scholar
• Hua C, Raffeld M, Ko HS, Fast P, Bakhshi A, Cossman J. Mechanism of bcl-2 activation in human follicular lymphoma. Oncogene 1990;5:233–235.
   PubMed Web of Science ®Google Scholar
• Vanasse GJ, Winn RK, Rodov S, et al Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Mol Cancer Res 2004;2:620–631.
   Google Scholar